This is the authors' abstract. We don't add key points for this paper.
MAINTENANCE ELECTROCONVULSIVE THERAPY (M-ECT) has been reported to be effective for preventing recurrence in some patients with antipsychotic treatment-resistant schizophrenia.1-3 Most patients, however, are treated with a combination of M-ECT and antipsychotics. Herein we describe a case of schizophrenia in which complete remission was maintained for 6 years on M-ECT alone. The patient, who was in a stable mental condition, gave the authors informed consent to publish this letter. The patient was a 71-year-old Japanese woman. At age 51 she had acute development of a delusion of being possessed by god, and marked disorganized behavior such as dashing out of her house. According to the DSM-IV criteria, the patient was diagnosed as having disorganized schizophrenia. Haloperidol and chlorpromazine significantly improved her symptoms, but these agents were soon discontinued on her decision due to tremor and akathisia. Her psychosis lasted for years partly because of intolerance and poor adherence to the various atypical antipsychotics. At age 63 she was admitted to hospital for treatment of exacerbated psychosis and probable malignant syndrome: symptoms consisted of marked tremor and muscle rigidity, fever, leukocytosis and elevated creatine phosphokinase. She also developed strangulated ileus, thus her treatment team decided to carry out bilateral ECT (Thymatron DG, Somatics, LLC, Lake Bluff, IL, USA) according to standard procedure after all psychotropic drugs were withdrawn. The patient responded dramatically to acute ECT and reached complete remission after the ninth trial. The 18-item brief psychiatric rating scale (BPRS) score was reduced from 44 to 5 at the last (13th) trial. The patient and her family members favored M-ECT alone after discharge. The average interval for ECT during the first year, next 2 years and the last 3 years was 1 month, 2 months and 5 months, respectively. During the 6-year follow-up period, the patient handled housework well and maintained remission from psychosis. At age 71, however, her psychosis abruptly recurred. Antipsychotic medication including aripiprazole was tried but her psychosis was strongly resistant to that. The patient also failed to respond to two subsequent courses of acute ECT (13 and eight trials, respectively). The third course of ECT, however, with 11 trials, dramatically alleviated her symptoms, resulting in complete remission (BPRS: 5). After 8-month hospitalization, she was discharged home and was attending the outpatient clinic for M-ECT. Abnormal electroencephalogram findings and definite cognitive decline have not been found to date. The present case report implies that M-ECT without antipsychotic medication may be a treatment option for antipsychotic-resistant or -intolerant schizophrenia. A controlled study, however, indicated that a combination of M-ECT and flupenthixol was superior to M-ECT monotherapy or flupenthixol.4 Further study is needed to identify schizophrenia patients who may benefit from M-ECT alone. Careful consideration should be given to the interval of M-ECT, as well as to the changes in cognitive function and cortical excitability that might induce epileptic seizures.5
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kitamura et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: